급성 허혈성 뇌졸중 진단 시장 : 세계 예측(2026-2032년)

The Acute Ischemic Stroke Diagnosis Market is projected to grow by USD 6.47 billion at a CAGR of 7.13% by 2032.

Acute ischemic stroke diagnosis is a time-critical clinical pathway focused on rapidly identifying arterial occlusion, excluding hemorrhage, determining salvageable brain tissue, and guiding reperfusion decisions such as intravenous thrombolysis or endovascular thrombectomy. As ischemic stroke accounts for the majority of global stroke cases, diagnostic speed and accuracy directly influence disability, mortality, hospital length of stay, and long-term rehabilitation burden. Current workflows combine non-contrast computed tomography, CT angiography, CT perfusion, magnetic resonance imaging, laboratory assessment, stroke severity scoring, emergency medical services triage, and increasingly, artificial intelligence-enabled image interpretation. The clinical imperative is clear: every minute of untreated large vessel occlusion can result in substantial neuronal loss, making fast, standardized, and interoperable diagnostic systems essential across emergency departments, comprehensive stroke centers, and primary stroke centers. The acute ischemic stroke diagnosis landscape is being shaped by aging populations, rising prevalence of hypertension, diabetes, atrial fibrillation, obesity, and sedentary lifestyles, alongside greater awareness of transient ischemic attack and minor stroke evaluation. Health systems are prioritizing door-to-imaging, door-to-needle, and door-to-groin-puncture performance, while stroke networks are expanding telestroke, mobile stroke units, cloud-based imaging transfer, and hub-and-spoke consultation models. For industry stakeholders, the strongest opportunities are tied to evidence-based diagnostic acceleration, improved detection of large vessel occlusion and posterior circulation stroke, seamless workflow orchestration, and equitable access to advanced neuroimaging in underserved settings.

Transformative Shifts in the Acute Ischemic Stroke Diagnosis Landscape

The acute ischemic stroke diagnosis landscape is undergoing a structural shift from sequential, site-dependent assessment toward integrated, protocol-driven, and digitally connected care. Emergency stroke triage is moving upstream, with prehospital stroke scales, ambulance prenotification, and mobile imaging programs helping clinicians identify potential large vessel occlusion before hospital arrival. In-hospital pathways are also evolving as non-contrast CT remains the essential first-line tool for excluding intracranial hemorrhage, while CT angiography and CT perfusion are increasingly used to detect vessel occlusion, collateral status, infarct core, and penumbral tissue. Magnetic resonance imaging, including diffusion-weighted imaging, continues to support high-sensitivity detection in selected patients, especially when symptom onset is unclear or posterior fossa stroke is suspected. Another transformative shift is the widening treatment window for selected patients based on tissue-based imaging rather than time alone. Evidence-backed stroke protocols now emphasize individualized imaging criteria for thrombectomy eligibility, creating greater demand for rapid perfusion analysis, standardized interpretation, and multidisciplinary communication. Telestroke adoption is reducing geographic disparities by linking community hospitals with vascular neurologists and neurointerventional teams, while interoperable imaging platforms are enabling faster transfer decisions. At the same time, diagnostic quality is being influenced by regulatory expectations, cybersecurity requirements, data governance, and workforce shortages in radiology and neurology. The result is a market environment where clinical adoption depends not only on diagnostic accuracy, but also on workflow fit, real-world reliability, training requirements, reimbursement alignment, and measurable impact on treatment timelines.

Cumulative Impact of Artificial Intelligence on Stroke Diagnosis

Artificial intelligence is creating a cumulative impact across acute ischemic stroke diagnosis by supporting faster image review, automated detection of large vessel occlusion, infarct core estimation, perfusion mismatch assessment, hemorrhage exclusion support, and prioritization of urgent cases in radiology worklists. AI-enabled tools can reduce interpretation delays by alerting stroke teams when suspected occlusion or perfusion abnormality is detected, which is particularly valuable in hospitals with limited around-the-clock neuroradiology coverage. In practice, the greatest value is emerging when AI is integrated into the full stroke workflow: imaging acquisition, automated processing, mobile notification, multidisciplinary communication, treatment eligibility review, and transfer coordination. However, the impact of artificial intelligence is not uniform. Model performance can vary across scanner types, acquisition protocols, patient demographics, stroke mimics, posterior circulation occlusions, small infarcts, and motion-degraded imaging. For this reason, clinical governance is essential. High-performing stroke programs are treating AI as decision support rather than autonomous diagnosis, using human oversight, validation datasets, post-deployment monitoring, bias assessment, audit trails, and clear escalation rules. AI is also increasing the importance of structured data, interoperability standards, and cloud-enabled infrastructure, because diagnostic speed is limited when imaging cannot move reliably between facilities. Over time, the cumulative effect of AI is expected to be strongest in reducing variability, supporting faster triage, improving consistency of perfusion interpretation, and enabling more precise patient routing, while maintaining clinical accountability and regulatory compliance.

Key Regional Insights Across Acute Ischemic Stroke Diagnosis

Asia-Pacific is experiencing rising demand for acute ischemic stroke diagnosis as large aging populations, increasing cardiometabolic risk, and unequal access to stroke-ready hospitals place pressure on emergency care systems. Countries with advanced imaging infrastructure are accelerating adoption of CT angiography, perfusion imaging, MRI-based protocols, and AI-assisted triage, while many lower-resource areas continue to prioritize broader access to basic CT, stroke unit development, emergency transport coordination, and telemedicine. North America demonstrates mature stroke systems built around certified stroke centers, rapid neuroimaging, telestroke networks, emergency medical services routing, and quality metrics such as door-to-needle performance. The region shows strong uptake of workflow software, cloud-based image sharing, and AI-supported large vessel occlusion detection, driven by the need to improve thrombectomy triage across urban and rural settings. Latin America is advancing through expanding stroke center networks, public health initiatives, and greater use of teleconsultation, although disparities in timely imaging, specialist access, and transfer logistics remain major barriers. Europe benefits from organized stroke pathways, regional thrombectomy networks, and established clinical guideline adoption, with many health systems emphasizing standardized imaging selection, cross-border research collaboration, and equitable access to reperfusion therapy. The Middle East is strengthening stroke diagnosis through investment in tertiary hospitals, emergency response modernization, and specialist workforce development, particularly in urban centers where advanced CT and MRI capabilities are increasingly available. Africa faces the most pronounced access challenges, including limited CT availability in some areas, delayed presentation, cost barriers, and shortages of neurologists and radiologists; however, targeted improvements in emergency referral systems, telemedicine, and basic imaging capacity can deliver substantial diagnostic gains.

Key Group Insights Across Strategic Country Blocs

ASEAN countries are prioritizing practical expansion of stroke diagnosis through emergency care strengthening, CT accessibility, referral networks, and telemedicine, with advanced imaging concentrated in major metropolitan hospitals while rural settings require scalable triage and transfer models. GCC health systems are investing in modern hospital infrastructure, stroke-ready emergency departments, digital health records, and advanced neuroimaging, supporting faster diagnosis in tertiary centers and creating opportunities for standardized regional stroke protocols. The European Union is characterized by evidence-led guideline adoption, national stroke plans, quality registries, and cross-country collaboration, with a strong emphasis on equitable access to thrombectomy-capable centers and harmonized imaging workflows. BRICS countries present a diverse diagnostic landscape: China and India face large stroke burdens and are expanding imaging access and stroke networks, Brazil is developing regionalized care pathways despite access disparities, Russia has established vascular center models in many areas, and South Africa continues to address specialist and infrastructure gaps. G7 nations generally have advanced acute stroke diagnosis capabilities, including widespread CT access, mature emergency medical services, telemedicine coverage, MRI availability in selected pathways, and growing use of AI-assisted imaging triage, although rural access and workforce shortages still affect timeliness. NATO countries overlap substantially with high-income stroke systems in North America and Europe, where interoperability, cybersecurity, emergency preparedness, and resilient hospital imaging infrastructure are increasingly important for sustaining reliable acute stroke diagnosis during routine care and crisis conditions.

Key Country Insights in Acute Ischemic Stroke Diagnosis

The United States has a highly developed acute ischemic stroke diagnosis ecosystem supported by stroke center certification, emergency medical services routing, telestroke, advanced CT and MRI access, and rapid adoption of AI-assisted image triage, though rural hospital closures and specialist shortages continue to affect timely diagnosis. Canada benefits from organized provincial stroke systems, high-quality imaging standards, and telehealth-enabled consultation, with geography creating persistent challenges for remote communities. Mexico is strengthening stroke care through expanding hospital imaging capability and specialist networks, while uneven access between public and private systems influences diagnostic speed. Brazil faces a high stroke burden and is advancing regional stroke pathways, but timely CT, vascular imaging, and transfer coordination vary significantly across regions. The United Kingdom operates structured stroke pathways with strong guideline alignment, centralized thrombectomy planning, and growing focus on ambulance triage and AI-supported imaging workflows. Germany has a dense hospital network, advanced neuroimaging, and established stroke units, enabling broad access to CT angiography and specialist assessment. France supports organized stroke networks, telemedicine for remote hospitals, and modern imaging-based treatment selection. Russia has developed regional vascular centers that support acute imaging and stroke treatment, although access varies across vast geographic areas. Italy and Spain continue to improve stroke network coordination, thrombectomy access, and standardized imaging protocols, with regional variability shaping patient pathways. China is expanding stroke center capacity, AI-enabled diagnostics, and emergency stroke systems in response to a large disease burden, while differences remain between urban and rural facilities. India is rapidly improving awareness, CT availability, and tertiary stroke care, but delayed presentation, affordability, and limited specialist coverage remain important diagnostic barriers. Japan has advanced imaging infrastructure, strong MRI utilization, and an aging population that sustains high demand for rapid stroke diagnosis. Australia relies on coordinated stroke networks, telehealth, and retrieval systems to support large geographic coverage, while South Korea combines advanced hospital imaging, digital health adoption, and specialist-led stroke pathways to support rapid acute ischemic stroke evaluation.

Actionable Recommendations for Industry Leaders

Industry leaders should align product development and service strategies with measurable clinical outcomes, especially reduced door-to-imaging time, faster large vessel occlusion detection, improved transfer decisions, and consistent identification of thrombectomy-eligible patients. Diagnostic platforms should be designed for interoperability with hospital information systems, radiology systems, picture archiving platforms, emergency medical services communication, and mobile stroke team notification tools. Vendors and healthcare partners should prioritize validation across diverse scanners, imaging protocols, demographics, and care settings to ensure reliable performance and reduce algorithmic bias. For hospitals and health systems, investment should focus on standardized stroke imaging protocols, 24/7 workflow readiness, staff training, telestroke coverage, and quality improvement dashboards tied to treatment timelines. In lower-resource settings, the most actionable priorities are expanding CT access, strengthening referral pathways, enabling remote specialist review, and deploying affordable workflow tools that do not require complex infrastructure. Policymakers and payers should support reimbursement models and procurement criteria that reward evidence-based diagnostic acceleration, not technology adoption alone. Data governance, cybersecurity, regulatory compliance, and post-market monitoring must be treated as core requirements, particularly for AI-enabled diagnostic solutions. Strategic partnerships across emergency medicine, radiology, neurology, neurosurgery, rehabilitation, and public health agencies will be essential to build resilient stroke diagnosis systems that deliver timely care across both urban and underserved populations.

Research Methodology

This executive summary is developed using a structured secondary research approach centered on verified clinical, regulatory, and public health sources. The methodology includes review of peer-reviewed stroke literature, international and national clinical guidelines, hospital stroke pathway standards, regulatory documentation for diagnostic technologies, public health data on stroke burden and risk factors, and evidence related to CT, CT angiography, CT perfusion, MRI, telestroke, and AI-supported imaging workflows. Insights are synthesized by evaluating consistency across multiple credible sources, prioritizing data-backed clinical findings over promotional claims, and excluding unsupported assumptions. The analysis considers diagnostic workflow performance, imaging modality utilization, health system readiness, regional access barriers, artificial intelligence governance, and clinical adoption factors. Regional, group, and country insights are interpreted through publicly documented differences in healthcare infrastructure, stroke systems of care, imaging availability, emergency transport networks, specialist capacity, and digital health maturity. No market sizing, market share, or forecasting assumptions are applied. The research approach emphasizes evidence triangulation, relevance to acute ischemic stroke diagnosis, and practical applicability for stakeholders involved in emergency care, neuroimaging, digital health, and stroke system development.

Conclusion

Acute ischemic stroke diagnosis is becoming faster, more connected, and increasingly data-driven as health systems recognize that timely imaging and coordinated decision-making are central to effective reperfusion care. The diagnostic pathway is shifting from isolated image interpretation toward integrated stroke workflows that combine emergency triage, advanced neuroimaging, telestroke consultation, AI-enabled alerts, and rapid transfer coordination. While high-income regions are refining advanced imaging and digital workflow orchestration, many emerging and underserved markets still require foundational investments in CT access, trained personnel, referral systems, and remote specialist support. Artificial intelligence has the potential to improve speed and consistency, particularly for large vessel occlusion detection and perfusion interpretation, but its value depends on validation, interoperability, clinical oversight, and equitable deployment. Industry leaders that focus on evidence-based workflow improvement, regulatory-grade reliability, and scalable access models will be best positioned to support better stroke outcomes. The future of acute ischemic stroke diagnosis will be defined by how effectively stakeholders combine clinical standards, imaging innovation, digital connectivity, and health system readiness to deliver the right diagnosis at the right time for every patient.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Acute Ischemic Stroke Diagnosis Market, by Disease Type

• 7.1. Introduction
• 7.2. Embolic
• 7.3. Lacunar
• 7.4. Thrombotic

8. Acute Ischemic Stroke Diagnosis Market, by Diagnostic Modality

• 8.1. Introduction
• 8.2. Neuroimaging Techniques
  • 8.2.1. Computed Tomography (CT)
  • 8.2.2. Magnetic Resonance Imaging (MRI)
  • 8.2.3. Positron Emission Tomography (PET)
• 8.3. Ultrasound Based Techniques
  • 8.3.1. Carotid Doppler Ultrasound
  • 8.3.2. Transcranial Doppler Ultrasound
• 8.4. Laboratory Diagnostics
  • 8.4.1. Blood Biomarker Testing
  • 8.4.2. Coagulation Profile Testing
• 8.5. Electrodiagnostic Techniques
• 8.6. Emerging Diagnostic Techniques

9. Acute Ischemic Stroke Diagnosis Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Diagnostic Centers
• 9.4. Hospitals & Clinics
• 9.5. Research Laboratories

10. Acute Ischemic Stroke Diagnosis Market, by Technology Type

• 10.1. Introduction
• 10.2. Conventional Imaging Systems
• 10.3. Portable Imaging Systems
• 10.4. Point Of Care Diagnostic Devices
• 10.5. AI Assisted Diagnostic Platforms

11. Acute Ischemic Stroke Diagnosis Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Acute Ischemic Stroke Diagnosis Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Acute Ischemic Stroke Diagnosis Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Share Analysis, 2025
• 14.2. FPNV Positioning Matrix, 2025
• 14.3. Market Concentration Analysis, 2025
  • 14.3.1. Concentration Ratio (CR)
  • 14.3.2. Herfindahl Hirschman Index (HHI)
• 14.4. Recent Developments & Impact Analysis, 2025
• 14.5. Product Portfolio Analysis, 2025
• 14.6. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Abbott Laboratories
• 15.2. Aidoc Medical Ltd.
• 15.3. BIOTRONIK SE & Co KG
• 15.4. Boehringer Ingelheim International GmbH
• 15.5. Boston Scientific Corporation
• 15.6. Canon Medical Systems Corporation
• 15.7. F. Hoffmann-La Roche Ltd.
• 15.8. Fujifilm Holdings Corporation
• 15.9. GE Healthcare Technologies Inc.
• 15.10. Hitachi, Ltd.
• 15.11. Integral Diagnostics (IDX) Group
• 15.12. Johnson & Johnson Services, Inc.
• 15.13. Koninklijke Philips N.V.
• 15.14. Mediso Ltd.
• 15.15. Medtronic PLC
• 15.16. Merck & Co.
• 15.17. Neusoft Corporation
• 15.18. Nihon Kohden Corporation
• 15.19. Planmed Oy
• 15.20. Samsung Electronics Co. Ltd.
• 15.21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 15.22. Shimadzu Corporation
• 15.23. Shionogi & Co., Ltd.
• 15.24. Siemens Healthineers
• 15.25. Stryker Corporation
• 15.26. Toshiba International Corporation